2024-11-20 18:31:42
Daewoong, first-in-class PRS-inhibitor for Idiopathic Pulmonary Fibrosis (IPF) shows promising result in early stage clinical test
Corporate/ 2023-07-23
Daewoong, first-in-class PRS-inhibitor f...

We confirmed the safety of \'DWN12088\' and secured grounds for establishing treatment dosage Confirming the potential as a treatment for IP...

Singapore-based HeMo Bioengineering Receives China's NMPA Approval for flagship Afentta(TM) Aspiration Catheter
Health/ 2023-07-22
Singapore-based HeMo Bioengineering Rece...

SINGAPORE,May 24,2021-- HeMo Bioengineering Ltd ("HeMo"),a Singapore-based medical device company with a focus on treating stroke ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release